Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Canada
0
South Africa
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Beloc Duriles
2. Beloc-duriles
3. Betaloc
4. Betaloc Astra
5. Betaloc-astra
6. Betalok
7. Cgp 2175
8. Cgp-2175
9. Cgp2175
10. H 93 26
11. H 93-26
12. H 9326
13. Lopressor
14. Metoprolol
15. Metoprolol Cr Xl
16. Metoprolol Cr-xl
17. Metoprolol Tartrate
18. Seloken
19. Spesicor
20. Spesikor
21. Toprol
22. Toprol Xl
23. Toprol-xl
1. 98418-47-4
2. Metroprolol Succinate
3. Selozok
4. Toprol Xl
5. Metoprolol (succinate)
6. Seloken-zok
7. H 93/26 Succinate
8. Toprol-xl
9. Metoprolol Hemisuccinate
10. Butanedioic Acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
11. Th25pd4ccb
12. Spesicor Dos
13. Seloken Zoc
14. Beloc- Zok
15. 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, Butanedioate (2:1) (salt)
16. Metoprolol Succinate [usan]
17. Unii-th25pd4ccb
18. Metoprololsuccinate
19. Metoprolol Succinate [usan:usp]
20. Toprol Xl (tn)
21. Metoprolol Succinate Extended-release Tablets
22. Metoprolol Succinate (usp)
23. (+-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol Succinate (2:1) (salt)
24. Dsstox_cid_28652
25. Dsstox_rid_82922
26. Dsstox_gsid_48726
27. Schembl40916
28. Chebi:6905
29. Chembl2356097
30. Dtxsid9048726
31. Metoprolol Succinate [mi]
32. Hms3886g21
33. Bcp02473
34. Metoprolol Succinate [vandf]
35. Tox21_113155
36. Hy-17503a
37. Metoprolol Succinate [mart.]
38. Mfcd23115896
39. S5341
40. Metoprolol Succinate [usp-rs]
41. Metoprolol Succinate [who-dd]
42. 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; Succinic Acid
43. Akos015856332
44. Bcp9000922
45. Ccg-270331
46. Cs-3158
47. Ks-1241
48. Ac-26570
49. Metoprolol Succinate [ep Impurity]
50. Metoprolol Succinate [orange Book]
51. Metoprolol Succinate [ep Monograph]
52. Cas-98418-47-4
53. Metoprolol Succinate [usp Monograph]
54. Ft-0628933
55. Dutoprol Component Metoprolol Succinate
56. D00635
57. Metoprolol Succinate Component Of Dutoprol
58. 418m474
59. A845856
60. Q-201401
61. Q27289962
62. Metoprolol Succinate, United States Pharmacopeia (usp) Reference Standard
63. Bis(1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol); Butanedioic Acid
64. Butanedioic Acid,1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
65. (+/-)-1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol Succinate (2:1) (salt)
66. 123245-49-8
67. 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+/-)-, Butanedioate (2:1) (salt)
Molecular Weight | 652.8 g/mol |
---|---|
Molecular Formula | C34H56N2O10 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 21 |
Exact Mass | 652.39349599 g/mol |
Monoisotopic Mass | 652.39349599 g/mol |
Topological Polar Surface Area | 176 Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 308 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 4 | |
---|---|
Drug Name | Metoprolol succinate |
Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
Active Ingredient | Metoprolol succinate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
Market Status | Prescription |
Company | Mylan Pharms; Wockhardt; Actavis Labs Fl; Reddys; Dr Reddys Labs |
2 of 4 | |
---|---|
Drug Name | Toprol-xl |
Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
Active Ingredient | Metoprolol succinate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
Market Status | Prescription |
Company | Astrazeneca |
3 of 4 | |
---|---|
Drug Name | Metoprolol succinate |
Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
Active Ingredient | Metoprolol succinate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
Market Status | Prescription |
Company | Mylan Pharms; Wockhardt; Actavis Labs Fl; Reddys; Dr Reddys Labs |
4 of 4 | |
---|---|
Drug Name | Toprol-xl |
Drug Label | TOPROL-XL, metoprolol succinate, is a beta1-selective (cardioselective) adrenoceptor blocking agent, for oral administration, available as extended-release tablets. TOPROL-XL has been formulated to provide a controlled and predictable release of meto... |
Active Ingredient | Metoprolol succinate |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | eq 25mg tartrate; eq 50mg tartrate; eq 200mg tartrate; eq 100mg tartrate |
Market Status | Prescription |
Company | Astrazeneca |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Adrenergic beta-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Metoprolol Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metoprolol Succinate, including repackagers and relabelers. The FDA regulates Metoprolol Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metoprolol Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Metoprolol Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Metoprolol Succinate supplier is an individual or a company that provides Metoprolol Succinate active pharmaceutical ingredient (API) or Metoprolol Succinate finished formulations upon request. The Metoprolol Succinate suppliers may include Metoprolol Succinate API manufacturers, exporters, distributors and traders.
click here to find a list of Metoprolol Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Metoprolol Succinate DMF (Drug Master File) is a document detailing the whole manufacturing process of Metoprolol Succinate active pharmaceutical ingredient (API) in detail. Different forms of Metoprolol Succinate DMFs exist exist since differing nations have different regulations, such as Metoprolol Succinate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Metoprolol Succinate DMF submitted to regulatory agencies in the US is known as a USDMF. Metoprolol Succinate USDMF includes data on Metoprolol Succinate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Metoprolol Succinate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Metoprolol Succinate suppliers with USDMF on PharmaCompass.
A Metoprolol Succinate CEP of the European Pharmacopoeia monograph is often referred to as a Metoprolol Succinate Certificate of Suitability (COS). The purpose of a Metoprolol Succinate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Metoprolol Succinate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Metoprolol Succinate to their clients by showing that a Metoprolol Succinate CEP has been issued for it. The manufacturer submits a Metoprolol Succinate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Metoprolol Succinate CEP holder for the record. Additionally, the data presented in the Metoprolol Succinate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Metoprolol Succinate DMF.
A Metoprolol Succinate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Metoprolol Succinate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Metoprolol Succinate suppliers with CEP (COS) on PharmaCompass.
A Metoprolol Succinate written confirmation (Metoprolol Succinate WC) is an official document issued by a regulatory agency to a Metoprolol Succinate manufacturer, verifying that the manufacturing facility of a Metoprolol Succinate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Metoprolol Succinate APIs or Metoprolol Succinate finished pharmaceutical products to another nation, regulatory agencies frequently require a Metoprolol Succinate WC (written confirmation) as part of the regulatory process.
click here to find a list of Metoprolol Succinate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metoprolol Succinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metoprolol Succinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metoprolol Succinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metoprolol Succinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metoprolol Succinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metoprolol Succinate suppliers with NDC on PharmaCompass.
Metoprolol Succinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metoprolol Succinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metoprolol Succinate GMP manufacturer or Metoprolol Succinate GMP API supplier for your needs.
A Metoprolol Succinate CoA (Certificate of Analysis) is a formal document that attests to Metoprolol Succinate's compliance with Metoprolol Succinate specifications and serves as a tool for batch-level quality control.
Metoprolol Succinate CoA mostly includes findings from lab analyses of a specific batch. For each Metoprolol Succinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metoprolol Succinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Metoprolol Succinate EP), Metoprolol Succinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metoprolol Succinate USP).
LOOKING FOR A SUPPLIER?